> top > docs > PMC:1892049 > spans > 28022-28690 > annotations

PMC:1892049 / 28022-28690 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T13790 0-3 NCBITaxon:10376 denotes EBV
T13791 79-87 SO_EXT:sequence_deletion_entity_or_process denotes deletion
T13792 122-130 SO_EXT:sequence_alteration_entity_or_process denotes mutation
T13793 175-182 CHEBI_PR_EXT:protein denotes protein
T13794 230-237 CHEBI_PR_EXT:protein denotes Protein
T13795 269-274 GO:0019835 denotes lysis
T13796 275-281 CHEBI_CHMO_EXT:buffer_solution denotes buffer
T13797 304-316 CHEBI:9750 denotes Triton X-100
T13798 324-332 CHEBI:60004 denotes cocktail
T13799 336-355 CHEBI_GO_EXT:peptidase_or_protease_or_proteinase_inhibitor denotes protease inhibitors
T13800 379-384 GO:0019835 denotes lysis
T13801 450-458 MOP:0000569 denotes reducing
T13802 466-472 CHEBI_CHMO_EXT:buffer_solution denotes buffer
T13803 544-547 CHEBI:8984 denotes SDS
T13804 577-587 GO:0042571 denotes antibodies
T13805 591-596 PR_EXT:000009158 denotes ITPR1
T13806 611-615 PR_EXT:000003676 denotes ACTB

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T13780 0-3 NCBITaxon:10376 denotes EBV
T13781 269-274 GO:0019835 denotes lysis
T13782 304-316 CHEBI:9750 denotes Triton X-100
T13783 324-332 CHEBI:60004 denotes cocktail
T13784 379-384 GO:0019835 denotes lysis
T13785 450-458 MOP:0000569 denotes reducing
T13786 544-547 CHEBI:8984 denotes SDS
T13787 577-587 GO:0042571 denotes antibodies
T13788 591-596 PR:000009158 denotes ITPR1
T13789 611-615 PR:000003676 denotes ACTB

craft-sa-dev

Id Subject Object Predicate Lexical cue
T13815 0-3 NN denotes EBV
T13816 17-29 NNS denotes lymphoblasts
T13817 4-16 VBN denotes immortalized
T13818 136-140 VBN denotes used
T13819 30-34 IN denotes from
T13820 35-40 CD denotes three
T13821 57-64 NNS denotes members
T13822 41-49 VBN denotes affected
T13823 50-56 NN denotes family
T13824 65-68 WP denotes who
T13825 69-74 VBP denotes carry
T13826 75-78 DT denotes the
T13827 79-87 NN denotes deletion
T13828 88-91 CC denotes and
T13829 92-95 CD denotes one
T13830 103-109 NN denotes member
T13831 96-102 NN denotes family
T13832 110-117 IN denotes without
T13833 118-121 DT denotes the
T13834 122-130 NN denotes mutation
T13835 131-135 VBD denotes were
T13836 196-200 VBD denotes came
T13837 141-143 IN denotes as
T13838 144-145 DT denotes a
T13839 165-171 NN denotes source
T13840 146-153 RB denotes readily
T13841 154-164 JJ denotes accessible
T13842 172-174 IN denotes of
T13843 175-182 NN denotes protein
T13844 182-183 : denotes ;
T13845 184-187 DT denotes all
T13846 188-195 NNS denotes samples
T13847 201-205 IN denotes from
T13848 206-213 NNS denotes members
T13849 214-216 IN denotes of
T13850 217-223 NN denotes family
T13851 224-228 NN denotes AUS1
T13852 228-229 . denotes .
T13853 229-395 sentence denotes Protein extraction was performed using lysis buffer containing 1× TBS, 1% Triton X-100, and a cocktail of protease inhibitors (Roche) with overnight lysis at −80 °C.
T13854 230-237 NN denotes Protein
T13855 238-248 NN denotes extraction
T13856 253-262 VBN denotes performed
T13857 249-252 VBD denotes was
T13858 263-268 VBG denotes using
T13859 269-274 NN denotes lysis
T13860 275-281 NN denotes buffer
T13861 282-292 VBG denotes containing
T13862 293-294 CD denotes 1
T13863 296-299 NN denotes TBS
T13864 294-295 SYM denotes ×
T13865 299-301 , denotes ,
T13866 301-302 CD denotes 1
T13867 302-303 NN denotes %
T13868 311-312 NN denotes X
T13869 304-310 NN denotes Triton
T13870 312-313 HYPH denotes -
T13871 313-316 CD denotes 100
T13872 316-318 , denotes ,
T13873 318-321 CC denotes and
T13874 322-323 DT denotes a
T13875 324-332 NN denotes cocktail
T13876 333-335 IN denotes of
T13877 336-344 NN denotes protease
T13878 345-355 NNS denotes inhibitors
T13879 356-357 -LRB- denotes (
T13880 357-362 NNP denotes Roche
T13881 362-363 -RRB- denotes )
T13882 364-368 IN denotes with
T13883 369-378 JJ denotes overnight
T13884 379-384 NN denotes lysis
T13885 385-387 IN denotes at
T13886 388-389 SYM denotes −
T13887 389-391 CD denotes 80
T13888 392-394 NN denotes °C
T13889 394-395 . denotes .
T13890 395-572 sentence denotes Homogenates were diluted appropriately, mixed with 4× reducing sample buffer, and loaded onto 4%–12% precast gradient gels (NuPAGE, Invitrogen) for SDS-PAGE and immunoblotting.
T13891 396-407 NNS denotes Homogenates
T13892 413-420 VBN denotes diluted
T13893 408-412 VBD denotes were
T13894 421-434 RB denotes appropriately
T13895 434-436 , denotes ,
T13896 436-441 VBN denotes mixed
T13897 442-446 IN denotes with
T13898 447-448 CD denotes 4
T13899 466-472 NN denotes buffer
T13900 448-449 SYM denotes ×
T13901 450-458 VBG denotes reducing
T13902 459-465 NN denotes sample
T13903 472-474 , denotes ,
T13904 474-477 CC denotes and
T13905 478-484 VBN denotes loaded
T13906 485-489 IN denotes onto
T13907 490-491 CD denotes 4
T13908 491-492 NN denotes %
T13909 514-518 NNS denotes gels
T13910 492-493 SYM denotes –
T13911 495-496 NN denotes %
T13912 493-495 CD denotes 12
T13913 497-504 JJ denotes precast
T13914 505-513 NN denotes gradient
T13915 519-520 -LRB- denotes (
T13916 520-526 NN denotes NuPAGE
T13917 526-528 , denotes ,
T13918 528-538 NNP denotes Invitrogen
T13919 538-539 -RRB- denotes )
T13920 540-543 IN denotes for
T13921 544-547 NN denotes SDS
T13922 548-552 NN denotes PAGE
T13923 547-548 HYPH denotes -
T13924 553-556 CC denotes and
T13925 557-571 NN denotes immunoblotting
T13926 571-572 . denotes .
T13927 572-668 sentence denotes The antibodies to ITPR1 (1:1,000) and ACTB (1:5,000) were used as recommended by manufacturers.
T13928 573-576 DT denotes The
T13929 577-587 NNS denotes antibodies
T13930 631-635 VBN denotes used
T13931 588-590 IN denotes to
T13932 591-596 NN denotes ITPR1
T13933 597-598 -LRB- denotes (
T13934 598-599 CD denotes 1
T13935 599-600 SYM denotes :
T13936 600-605 CD denotes 1,000
T13937 605-606 -RRB- denotes )
T13938 607-610 CC denotes and
T13939 611-615 NN denotes ACTB
T13940 616-617 -LRB- denotes (
T13941 617-618 CD denotes 1
T13942 618-619 SYM denotes :
T13943 619-624 CD denotes 5,000
T13944 624-625 -RRB- denotes )
T13945 626-630 VBD denotes were
T13946 636-638 IN denotes as
T13947 639-650 VBN denotes recommended
T13948 651-653 IN denotes by
T13949 654-667 NNS denotes manufacturers
T13950 667-668 . denotes .
R4070 T13815 T13816 nmod EBV,lymphoblasts
R4071 T13816 T13818 nsubjpass lymphoblasts,used
R4072 T13817 T13816 amod immortalized,lymphoblasts
R4073 T13818 T13836 ccomp used,came
R4074 T13819 T13816 prep from,lymphoblasts
R4075 T13820 T13821 nummod three,members
R4076 T13821 T13819 pobj members,from
R4077 T13822 T13821 amod affected,members
R4078 T13823 T13821 compound family,members
R4079 T13824 T13825 dep who,carry
R4080 T13825 T13821 relcl carry,members
R4081 T13826 T13827 det the,deletion
R4082 T13827 T13825 dobj deletion,carry
R4083 T13828 T13821 cc and,members
R4084 T13829 T13830 nummod one,member
R4085 T13830 T13821 conj member,members
R4086 T13831 T13830 compound family,member
R4087 T13832 T13830 prep without,member
R4088 T13833 T13834 det the,mutation
R4089 T13834 T13832 pobj mutation,without
R4090 T13835 T13818 auxpass were,used
R4091 T13837 T13818 prep as,used
R4092 T13838 T13839 det a,source
R4093 T13839 T13837 pobj source,as
R4094 T13840 T13841 advmod readily,accessible
R4095 T13841 T13839 amod accessible,source
R4096 T13842 T13839 prep of,source
R4097 T13843 T13842 pobj protein,of
R4098 T13844 T13836 punct ;,came
R4099 T13845 T13846 det all,samples
R4100 T13846 T13836 nsubj samples,came
R4101 T13847 T13836 prep from,came
R4102 T13848 T13847 pobj members,from
R4103 T13849 T13848 prep of,members
R4104 T13850 T13851 compound family,AUS1
R4105 T13851 T13849 pobj AUS1,of
R4106 T13852 T13836 punct .,came
R4107 T13854 T13855 compound Protein,extraction
R4108 T13855 T13856 nsubjpass extraction,performed
R4109 T13857 T13856 auxpass was,performed
R4110 T13858 T13856 advcl using,performed
R4111 T13859 T13860 compound lysis,buffer
R4112 T13860 T13858 dobj buffer,using
R4113 T13861 T13860 acl containing,buffer
R4114 T13862 T13863 nummod 1,TBS
R4115 T13863 T13861 dobj TBS,containing
R4116 T13864 T13862 punct ×,1
R4117 T13865 T13863 punct ", ",TBS
R4118 T13866 T13867 nummod 1,%
R4119 T13867 T13868 compound %,X
R4120 T13868 T13863 conj X,TBS
R4121 T13869 T13868 compound Triton,X
R4122 T13870 T13868 punct -,X
R4123 T13871 T13868 nummod 100,X
R4124 T13872 T13868 punct ", ",X
R4125 T13873 T13868 cc and,X
R4126 T13874 T13875 det a,cocktail
R4127 T13875 T13868 conj cocktail,X
R4128 T13876 T13875 prep of,cocktail
R4129 T13877 T13878 compound protease,inhibitors
R4130 T13878 T13876 pobj inhibitors,of
R4131 T13879 T13880 punct (,Roche
R4132 T13880 T13878 parataxis Roche,inhibitors
R4133 T13881 T13880 punct ),Roche
R4134 T13882 T13856 prep with,performed
R4135 T13883 T13884 amod overnight,lysis
R4136 T13884 T13882 pobj lysis,with
R4137 T13885 T13856 prep at,performed
R4138 T13886 T13887 punct −,80
R4139 T13887 T13888 nummod 80,°C
R4140 T13888 T13885 pobj °C,at
R4141 T13889 T13856 punct .,performed
R4142 T13891 T13892 nsubjpass Homogenates,diluted
R4143 T13893 T13892 auxpass were,diluted
R4144 T13894 T13892 advmod appropriately,diluted
R4145 T13895 T13892 punct ", ",diluted
R4146 T13896 T13892 conj mixed,diluted
R4147 T13897 T13896 prep with,mixed
R4148 T13898 T13899 nummod 4,buffer
R4149 T13899 T13897 pobj buffer,with
R4150 T13900 T13898 punct ×,4
R4151 T13901 T13899 amod reducing,buffer
R4152 T13902 T13899 compound sample,buffer
R4153 T13903 T13896 punct ", ",mixed
R4154 T13904 T13896 cc and,mixed
R4155 T13905 T13896 conj loaded,mixed
R4156 T13906 T13905 prep onto,loaded
R4157 T13907 T13908 nummod 4,%
R4158 T13908 T13909 nmod %,gels
R4159 T13909 T13906 pobj gels,onto
R4160 T13910 T13911 punct –,%
R4161 T13911 T13908 prep %,%
R4162 T13912 T13911 nummod 12,%
R4163 T13913 T13909 amod precast,gels
R4164 T13914 T13909 compound gradient,gels
R4165 T13915 T13916 punct (,NuPAGE
R4166 T13916 T13909 parataxis NuPAGE,gels
R4167 T13917 T13916 punct ", ",NuPAGE
R4168 T13918 T13916 appos Invitrogen,NuPAGE
R4169 T13919 T13916 punct ),NuPAGE
R4170 T13920 T13905 prep for,loaded
R4171 T13921 T13922 compound SDS,PAGE
R4172 T13922 T13920 pobj PAGE,for
R4173 T13923 T13922 punct -,PAGE
R4174 T13924 T13922 cc and,PAGE
R4175 T13925 T13922 conj immunoblotting,PAGE
R4176 T13926 T13892 punct .,diluted
R4177 T13928 T13929 det The,antibodies
R4178 T13929 T13930 nsubjpass antibodies,used
R4179 T13931 T13929 prep to,antibodies
R4180 T13932 T13931 pobj ITPR1,to
R4181 T13933 T13934 punct (,1
R4182 T13934 T13932 parataxis 1,ITPR1
R4183 T13935 T13936 punct :,"1,000"
R4184 T13936 T13934 prep "1,000",1
R4185 T13937 T13934 punct ),1
R4186 T13938 T13932 cc and,ITPR1
R4187 T13939 T13932 conj ACTB,ITPR1
R4188 T13940 T13941 punct (,1
R4189 T13941 T13939 parataxis 1,ACTB
R4190 T13942 T13943 punct :,"5,000"
R4191 T13943 T13941 prep "5,000",1
R4192 T13944 T13941 punct ),1
R4193 T13945 T13930 auxpass were,used
R4194 T13946 T13947 mark as,recommended
R4195 T13947 T13930 advcl recommended,used
R4196 T13948 T13947 agent by,recommended
R4197 T13949 T13948 pobj manufacturers,by
R4198 T13950 T13930 punct .,used